These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 6177865)
1. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. Strnad BC; Schuster T; Klein R; Hopkins RF; Witmer T; Neubauer RH; Rabin H J Virol; 1982 Jan; 41(1):258-64. PubMed ID: 6177865 [TBL] [Abstract][Full Text] [Related]
2. Glycosylation pathways of two major Epstein-Barr virus membrane antigens. Strnad BC; Adams MR; Rabin H Virology; 1983 May; 127(1):168-76. PubMed ID: 6305014 [TBL] [Abstract][Full Text] [Related]
3. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein. Qualtiere LF; Chase R; Vroman B; Pearson GR Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies. Yokochi T; Clark EA; Kimura Y Virology; 1986 Jan; 148(1):114-20. PubMed ID: 3002025 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689 [TBL] [Abstract][Full Text] [Related]
6. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins. Strnad BC; Neubauer RH; Rabin H; Mazur RA J Virol; 1979 Dec; 32(3):885-94. PubMed ID: 92577 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Thorley-Lawson DA; Geilinger K Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073 [TBL] [Abstract][Full Text] [Related]
9. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies. Tsai CH; Glaser R Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827 [TBL] [Abstract][Full Text] [Related]
10. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines. Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Hoffman GJ; Lazarowitz SG; Hayward SD Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus. Takada K; Fujiwara S; Yano S; Osato T Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies. Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376 [TBL] [Abstract][Full Text] [Related]
15. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody. Maunders MJ; Petti L; Rowe M J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118 [TBL] [Abstract][Full Text] [Related]
16. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen. Hank JA; Sondel PM Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. Orvell C; Norrby E; Mufson MA J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224 [TBL] [Abstract][Full Text] [Related]
19. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines. Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]